Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain

Projekt: Typer af projekterProjekt

Vis graf over relationer
StatusIgangværende
Periode01/08/2005 → …
URLhttp://clinicaltrials.gov/ct/show/NCT00256932?order=77
Forskningsprogram<ingen navn>

ID: 32489459